Overview
Kenichi Suda practices practicing medicine in Osaka, Japan.
Mr. Suda is highly rated in 5 conditions, according to our data. His clinical expertise encompasses EGFR Positive Lung Cancer, Lung Cancer, Lung Adenocarcinoma, and Non-Small Cell Lung Cancer (NSCLC).
He is actively involved in clinical research, co-authoring 131 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Kenichi Suda
Is Kenichi Suda a top-rated expert for EGFR Positive Lung Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Kenichi Suda is classified as an Elite expert for EGFR Positive Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Kenichi Suda participate in research or clinical trials?
Yes. Kenichi Suda has published 131 articles and abstracts on conditions like EGFR Positive Lung Cancer. You can view a list of Kenichi Suda's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- EGFR Positive Lung Cancer
- Lung CancerMr. Suda isElite. Learn about Lung Cancer.
- Distinguished
- Lung AdenocarcinomaMr. Suda isDistinguished. Learn about Lung Adenocarcinoma.
- Non-Small Cell Lung Cancer (NSCLC)Mr. Suda isDistinguished. Learn about Non-Small Cell Lung Cancer (NSCLC).
- Advanced
- Small Cell Lung Cancer (SCLC)Mr. Suda isAdvanced. Learn about Small Cell Lung Cancer (SCLC).
- Experienced
- Adenoid Cystic CarcinomaMr. Suda isExperienced. Learn about Adenoid Cystic Carcinoma.
- Lung MetastasesMr. Suda isExperienced. Learn about Lung Metastases.
- Lung NodulesMr. Suda isExperienced. Learn about Lung Nodules.
- Neuroendocrine TumorMr. Suda isExperienced. Learn about Neuroendocrine Tumor.
- PIK3CA-Related Overgrowth SpectrumMr. Suda isExperienced. Learn about PIK3CA-Related Overgrowth Spectrum.
- Squamous Cell Lung CarcinomaMr. Suda isExperienced. Learn about Squamous Cell Lung Carcinoma.